{"lastClose": 37.0, "len": 269, "date": "2023-02-02", "alpha_1": 2.032507931385069, "beta_1": 0.9677719257150802, "drawup_1": 4.9751826094910365, "sharpe_1": 0.9550834531534255, "natr_1": 5.916803139936256, "sup_1": -0.1613062867173203, "res_1": 0.250360394383336, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 52.148629457741166, "adx_1": 14.052837404550042, "drawdown_1": -0.7917933256250944, "stratHoldSharpe_1": 0.9516983114171, "stratHoldAlpha_1": 251.9319126171552, "stratHoldDrawdown_1": -0.7360836538726062, "alpha_3mo": 0.40877237699712454, "beta_3mo": 1.0345419102830313, "drawup_3mo": 0.24786589198847264, "sharpe_3mo": 0.8552017399115376, "natr_3mo": 5.916803139936256, "sup_3mo": -0.02758558805998375, "res_3mo": 0.05988287710928715, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 50.0, "adx_3mo": 21.466469400372652, "drawdown_3mo": -0.15231787564688803, "stratHoldSharpe_3mo": 1.234359250345628, "stratHoldAlpha_3mo": 251.57185440001928, "stratHoldDrawdown_3mo": -0.13937949472201727, "Industry": "Biotechnology: Pharmaceutical Preparations", "Sector": "Health Care", "Market Cap": 2450817504, "Name": "Amylyx Pharmaceuticals Inc.", "IPO Year": 2022.0, "Country": "United States", "alpha%_1": 0.9999999999983122, "beta%_1": 0.489752367453474, "drawup%_1": 1.0, "sharpe%_1": 0.6097623377074256, "natr%_1": 0.8288251304826022, "drawdown%_1": 0.022211610505547038, "stratHoldSharpe%_1": 0.8657307842475334, "stratHoldAlpha%_1": 0.9997751604264846, "stratHoldDrawdown%_1": 0.019250789186146016, "alpha%_3mo": 0.5707843639626595, "beta%_3mo": 0.5239675997188734, "drawup%_3mo": 0.44208722601223555, "sharpe%_3mo": 0.09001807055435151, "natr%_3mo": 0.8231398134485723, "drawdown%_3mo": 0.49811958800139794, "stratHoldSharpe%_3mo": 0.4104112704743528, "stratHoldAlpha%_3mo": 0.508514885973571, "stratHoldDrawdown%_3mo": 0.4928649755961465}